The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...
Abbott India Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Scrap and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the ...
Oil India Ltd. key Products/Revenue Segments include Oil Crude, Gas Natural, Income From Transportation Services, Renewable Energy System, Condensate for the year ending 31-Mar-2024.For the quarter ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...